Increased permeability of human erythrocytes induced by amphotericin B.
D000328:Adult; D000666:Amphotericin B / Q000009:adverse effects / Q000037:antagonists & inhibitors / Q000378:metabolism / Q000494:pharmacology*; D000740:Anemia / Q000139:chemically induced; D002463:Cell Membrane Permeability / Q000187:drug effects*; D003470:Culture Media; D004912:Erythrocytes / Q000187:drug effects* / Q000378:metabolism; D006801:Humans; D006863:Hydrogen-Ion Concentration; D008297:Male; D009181:Mycoses / Q000188:drug therapy; D009996:Osmotic Fragility; D010042:Ouabain / Q000494:pharmacology; D010949:Plasma; D011188:Potassium / Q000378:metabolism; D012965:Sodium Chloride; D013268:Stimulation, Chemical; D013696:Temperature
D003470:Culture Media; D012965:Sodium Chloride; D010042:Ouabain; D000666:Amphotericin B; D011188:Potassium